What Bendable Therapy does

Bendable Therapy is a Bend, Oregon-based 501(c)(3) nonprofit operating one of the first licensed psilocybin service centers under Oregon's Measure 109 framework. The organization delivers a three-phase psilocybin therapy protocol (preparation, supervised in-person session at the licensed service center, and structured integration support) priced at $3,800 all-inclusive, and complements this with traditional mental health counseling ($150–$187.50 per session) for Oregon residents in-person and via telehealth. The facilitation team is uniformly dual-licensed in mental health, exceeding Oregon's minimum facilitator requirements, and the organization operates an active IRB-approved research program in partnership with Osmind and UCSF's Robin Carhart-Harris, producing the first systematic real-world outcomes study of legal U.S. psilocybin services (n=88).

The business model is hybrid: service fees from psilocybin therapy and counseling, tax-deductible donations from individuals and grants from organizations (including a $50,000 Dr. Bronner's sponsorship and Jurvetson Foundation research funding), and — as of April 2025 — private insurance reimbursements through the Enthea partnership, making Bendable the first Oregon psilocybin center to offer insurance coverage. More than $300,000 in scholarships has been awarded to clients since opening, supporting a stated mission of access expansion. Clients are acquired via a free 45-minute consultation intake, organic search, earned media (NYT, OPB, Willamette Week, Bend Bulletin), social channels, and community referrals; psilocybin clients travel to Oregon from across the U.S., while counseling is geographically restricted to Oregon residents.

Beyond clinical services, Bendable is positioning itself as the primary evidence-generating site for Oregon's regulatory model, with a published n=88 outcomes study (medRxiv preprint, March 2026), a first-of-its-kind CRPS chronic pain study, and conference presentations at Psych Congress 2025, Horizons, and the American Counseling Association. The organization is structured as a mission-driven nonprofit with no parent company, no venture capital backing, and a board spanning public safety, integrative health, and clinical mental health expertise.

Name

Bendable Therapy

Legal name

Bendable Therapy

Website

https://bendabletherapy.org

Company type

Private

Founded year

2023

Operating status

Operating

Headcount range

1–10 employees

Short description

Bendable Therapy is an Oregon-based 501(c)(3) nonprofit operating a licensed psilocybin service center under Measure 109, delivering $3,800 all-inclusive psilocybin-assisted therapy and mental health counseling to adults with treatment-resistant conditions, veterans, and Oregon residents, while conducting IRB-approved outcomes research with Osmind and UCSF.

Ownership category

akta.pro rank

Headquarters

HQ city

Bend

HQ country

United States

HQ region

North America

Offices1 record

Markets served

GTM type

B2C

Offering type

Services

Cost components

Personnel, Operations, Infrastructure, Technology or R&D, Marketing or Sales

Revenue model

1. Psilocybin Therapy Program Fees: Bendable charges an all-inclusive fee of $3,800 per client for its comprehensive psilocybin therapy program. The fee covers preparation sessions, the in-person psilocybin session at the licensed service center, integration sessions, and ongoing access to integration groups and resources.
2. Mental Health Counseling Fees: Traditional mental health counseling sessions are charged at $150 per 55-minute ongoing session, $187.50 for EMDR sessions (75 minutes), and $187.50 for the initial intake (75 minutes). A limited sliding scale is available for clients with financial hardship. The practice is private-pay only and does not accept insurance directly, though superbills are provided for out-of-network reimbursement.
3. Donations and Sponsorships: As a 501(c)(3) nonprofit, Bendable receives tax-deductible donations from individuals and organizations. Dr. Bronner's provided a $50,000 sponsorship for the scholarship fund. The organization also receives funding from The Jurvetson Foundation for research activities. Donations fund client scholarships and research programs.
4. Insurance Reimbursement (Enthea Partnership): Through a partnership with Enthea, the only licensed benefits provider covering psychedelic mental health treatments, Bendable became the first psilocybin service center in Oregon to offer private insurance coverage for its program, enabling clients to use insurance benefits to cover treatment costs.

Pricing tiers

Go-to-market motion2 records

Distribution channels3 records

Marketing channels6 records

Core offering

Bendable Therapy is an Oregon-based 501(c)(3) nonprofit that delivers legal psilocybin-assisted therapy at a licensed service center in Bend, Oregon, in addition to traditional mental health counseling for Oregon residents. The organization operates an IRB-approved research program that produces real-world evidence on psilocybin service outcomes, and it partners with Enthea to offer private insurance reimbursement for eligible clients.

Product overview

Bendable Therapy is an Oregon-based nonprofit offering two core service lines: Psilocybin (Mushroom) Therapy and Mental Health Counseling. The Psilocybin Therapy program is a comprehensive protocol including preparation sessions, supervised psilocybin sessions at a licensed Oregon service center, and therapeutic integration support ($3,800 all-inclusive). Mental Health Counseling provides traditional therapy using evidence-based modalities (EMDR, Somatic Therapy, IFS, DBT, Existential Therapy) for Oregon residents. The company also operates a research program in partnership with Osmind and academic institutions, producing real-world evidence on psilocybin therapy outcomes. Additional offerings include a scholarship program (over $300,000 awarded), integration groups, and free consultations. Psilocybin therapy is available nationwide (with in-person sessions in Oregon) while counseling is limited to Oregon residents.

Differentiator

Problem solved

Functional benefit

Products and services

• Psilocybin (Mushroom) Therapy Program
• Mental Health Counseling

Quantifiable outcome

• 97% of participants reported improvement in anxiety and depression following psilocybin-assisted therapy (n=88 real-world study, March 2024–April 2025)
• +7 more outcomes

Named customers3 records

Segments4 records

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Integration4 records

Feature3 records

Partnerships

Four partnerships are on record, tiered core and minor.

• OsmindcoreTechnology or Integration · 1 September 2025Osmind is a mental health research technology company that provides data infrastructure for Bendable's outcomes studies. Through this partnership, structured outcomes data is analyzed using Osmind's validated mental health research platform. Bendable and Osmind co-presented the first real-world outcomes data from legal U.S. psilocybin services at Psych Congress 2025 (San Diego) and jointly authored the IRB-approved n=88 study published as a medRxiv preprint. They also partnered on the CRPS chronic pain study.
• Robin Carhart-Harris (UCSF Weill Institute for Neurosciences)coreStrategic or Co-development Partner · 1 September 2025Dr. Robin Carhart-Harris, Professor of Neurology and Psychiatry at UCSF and one of the world's leading psychedelic researchers, collaborated with Bendable on study protocol development for the n=88 real-world evidence study of Oregon's legal psilocybin program. He co-authored the published preprint and is credited as a key collaborator in Bendable's research program.
• EntheacoreGTM or Marketing Partner · 1 April 2025Enthea is the only licensed benefits provider currently covering psychedelic mental health treatments. Through this partnership, Bendable became the first psilocybin service center in Oregon to offer private insurance coverage for its program. This partnership was covered by Willamette Week and Bend Bulletin as a pivotal step toward integrating psychedelic care into mainstream mental health treatment.
• Healing Advocacy FundminorOthersBendable's Ryan Reid serves as an advisor on the Healing Advocacy Fund's safety committee, supporting responsible implementation of psilocybin programs nationwide. The organization is listed as a partner and collaborator on Bendable's website alongside other research and clinical partners.

Scale indicators11 records

Recent moves6 records

Expansion highlights6 records

Broad incumbents

• Compass Pathways: Public clinical-stage company developing psilocybin therapy (COMP360) for treatment-resistant depression, with active Phase 3 trials and a broad R&D and commercialization footprint. A much larger, well-capitalized player in psilocybin-assisted therapy targeting similar indications but pursuing a pharmaceutical regulatory pathway rather than Oregon-style service-center delivery.
• MAPS Public Benefit Corporation (MAPS PBC): Public benefit corporation focused on MDMA-assisted therapy for PTSD, pursuing FDA approval and operating training programs for psychedelic therapists. Adjacent in the psychedelic-assisted mental health therapy category but focused on MDMA rather than psilocybin and on a drug-approval pathway.
• Atai Life Sciences: Public clinical-stage biopharmaceutical company developing psychedelic and non-psychedelic therapies for mental health conditions including treatment-resistant depression. Larger, well-capitalized player pursuing drug-development pathway; comparable target indications to Bendable's psilocybin program.
• MindMed: Public clinical-stage neuroscience company developing psychedelic-inspired therapies (including LSD and MDMA programs) for anxiety, ADHD, and other mental health conditions. Comparable category positioning in psychedelic-assisted mental health treatment with significantly larger capital base.

Direct peers

• Field Trip Health: Now operating as Delic Holdings/See Me RX, Field Trip ran a network of psychedelic therapy clinics in the U.S. and Canada focused on ketamine-assisted therapy for depression and anxiety. Comparable business model offering psychedelic-assisted mental health treatment with preparation and integration support, though using ketamine rather than psilocybin.
• Synthesis Institute: Legal psilocybin retreat and training organization operating in the Netherlands and exploring U.S. expansion. Comparable truffle/Psilocybin-assisted therapy model with preparation and integration programming for personal growth and mental health, though outside Oregon's Measure 109 framework.
• Journey Service Center: Licensed psilocybin service center in Oregon operating under Measure 109, offering supervised psilocybin sessions in a comparable three-phase (preparation, session, integration) model. Direct competitor for Bendable's Oregon catchment area and out-of-state clients traveling for legal psilocybin services.

Emerging players

• Innerwell: Ketamine-assisted psychotherapy provider offering at-home and in-clinic ketamine treatment for depression, anxiety, PTSD, and other mental health conditions. Overlapping target market (treatment-resistant mental health, psychedelic-assisted therapy) with a remote-delivery model that competes for the same consumer pool.
• Mindbloom: Ketamine therapy provider offering at-home ketamine-assisted treatment for anxiety, depression, and PTSD across multiple U.S. states. Overlapping target market (treatment-resistant mental health) with a remote-delivery model that contrasts with Bendable's in-person Oregon-only model.

Others

• Enthea: Licensed benefits provider and Bendable's insurance partner — the only company currently offering insurance coverage for psychedelic mental health treatments. Critical ecosystem enabler whose broader payer relationships directly affect Bendable's reimbursement channel and patient access.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat4 records

Key risks7 records

Key highlights7 records

Customer concentration

• Facebookfacebook.com/Bendable-Therapy-61557777847416
• LinkedInlinkedin.com/company/bendable-therapy
• Instagraminstagram.com/bendabletherapy

Compliance1 record

Revenue estimate

Valuation estimate

Number of profiles

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Bendable Therapy